Table 4.
Baseline characteristics in propensity score matched population.
| ACE-I/ARB (n = 18) | No ACE-I/ARB (n = 36) | P value | |
|---|---|---|---|
| Age, years | 68.0 (60.0–76.0) | 71.0 (58.0–83.0) | 0.680 |
| Sex, male n, % | 14 (77.8) | 18 (50.0) | 0.078 |
| BMI, kg/m2 (n = 42) | 25.2 ± 2.7 | 23.2 ± 3.6 | 0.116 |
| NEWS | 4.0 ± 3.5 | 3.9 ± 3.1 | 0.883 |
| Days from symptom onset to diagnosis | 8.7 ± 7.6 | 6.7 ± 5.8 | 0.317 |
| Comorbid diseases, n (%) | |||
| Diabetes | 5 (27.8) | 12 (33.3) | 0.763 |
| Hypertension | 9 (50.0) | 19 (52.8) | 1.000 |
| Chronic lung disease | 2 (11.1) | 2 (5.6) | 0.462 |
| Tumor | 2 (11.1) | 3 (8.3) | 0.740 |
| Heart failure | 0 (0.0) | 1 (2.8) | 0.475 |
| Coronary heart disease | 1 (5.6) | 3 (8.3) | 0.713 |
| Chronic kidney disease | 2 (11.1) | 6 (16.7) | 0.588 |
| End-stage kidney disease | 1 (5.6) | 3 (8.3) | 0.713 |
| CCI | 3.7 ± 1.8 | 4.1 ± 2.5 | 0.586 |
BMI, body mass index; CCI, Charlson Comorbidity Index; NEWS, National Early Warning Score.